These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37480308)

  • 1. MAY PPAR GAMMA BE SIGNIFICANT IN BIPOLAR DISORDER ONLY IN THE PRESENCE OF METABOLIC SYNDROME?
    Kok Kendirlioglu B; Cihnioglu R; Kalelioglu T; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Karamustafalioglu N
    Psychiatr Danub; 2023; 35(2):210-219. PubMed ID: 37480308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder.
    Kok Kendirlioglu B; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Cihnioglu R; Kalelioglu T; Ilnem MC; Karamustafalioglu N
    Nord J Psychiatry; 2020 Feb; 74(2):83-88. PubMed ID: 31575320
    [No Abstract]   [Full Text] [Related]  

  • 3. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Levels in Adolescent with Bipolar Disorder and Their Relationship with Metabolic Parameters.
    Kasak M; Ceylan MF; Hesapcioglu ST; Senat A; Erel Ö
    J Mol Neurosci; 2022 Jun; 72(6):1313-1321. PubMed ID: 35318563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil to lymphocyte and monocyte to high-density lipoprotein ratios are promising inflammatory indicators of bipolar disorder.
    Kulacaoglu F; Yıldırım YE; Aslan M; İzci F
    Nord J Psychiatry; 2023 Jan; 77(1):77-82. PubMed ID: 36074909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
    Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome and its clinical correlates among patients with bipolar disorder.
    Kumar A; Narayanaswamy JC; Venkatasubramanian G; Raguram R; Grover S; Aswath M
    Asian J Psychiatr; 2017 Apr; 26():109-114. PubMed ID: 28483070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury?
    Ozpercin PU; Kendirlioglu BK; Sozen S; Yuksel O; Cihnioğlu R; Kalelioglu T; Karamustafalioglu N
    Psychoneuroendocrinology; 2018 Apr; 90():122-126. PubMed ID: 29482134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabolic syndrome as a mediator in the relationship between CCL11 levels and the presence of a mood episode with mixed features in young adults with bipolar disorder.
    Bender LV; Wirowski N; Lobato AS; Jansen K; Cardoso TA; Mondin TC; Oses JP; Kapczinski F; Souza LDM; Silva RAD; Pedrotti Moreira F
    J Psychiatr Res; 2024 Jul; 175():343-349. PubMed ID: 38761516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.
    Vares EA; Lehmann S; Sauer C; Pariante C; Wieland F; Soltmann B; Bauer M; Ritter P
    J Affect Disord; 2020 Dec; 277():450-455. PubMed ID: 32871531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study: Metabolic syndrome in current depressive episode.
    Moreira FP; Jansen K; Cardoso TA; Mondin TC; Magalhães PVDS; Kapczinski F; Souza LDM; da Silva RA; Oses JP; Wiener CD
    J Psychiatr Res; 2017 Sep; 92():119-123. PubMed ID: 28433948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines and ghrelin level of bipolar patients from manic episode to euthymic episode.
    Tunçel ÖK; Sarısoy G; Bilgici B; Pazvantoğlu O; Çetin E; Tunçel EK
    Nord J Psychiatry; 2018 Feb; 72(2):150-156. PubMed ID: 29132244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls.
    Silarova B; Giltay EJ; Van Reedt Dortland A; Van Rossum EF; Hoencamp E; Penninx BW; Spijker AT
    J Psychosom Res; 2015 Apr; 78(4):391-8. PubMed ID: 25742722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: A proton magnetic resonance spectroscopy study.
    Lai S; Zhong S; Liao X; Wang Y; Huang J; Zhang S; Sun Y; Zhao H; Jia Y
    J Affect Disord; 2018 Jan; 225():108-116. PubMed ID: 28818755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.
    Prossin AR; Zalcman SS; Evans SJ; McInnis MG; Ellingrod VL
    Ther Drug Monit; 2013 Apr; 35(2):194-202. PubMed ID: 23503445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal and inflammatory signatures of different mood episodes in bipolar disorder: a large-scale clinical study.
    Lyu N; Zhao Q; Fu B; Li J; Wang H; Yang F; Liu S; Huang J; Zhang X; Zhang L; Li R
    BMC Psychiatry; 2023 Jun; 23(1):449. PubMed ID: 37340368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. May oxytocin be a trait marker for bipolar disorder?
    Turan T; Uysal C; Asdemir A; Kılıç E
    Psychoneuroendocrinology; 2013 Dec; 38(12):2890-6. PubMed ID: 24080188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early intervention in bipolar affective disorders: Why, when and how].
    Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
    Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.